ProBiora Health, LLC, an entity owned by Ms. Christine L. Koski, has agreed to buy the consumer probiotic business of Oragenics, Inc. for $1.7 million in cash.
Investment experts and industry-leading entrepreneurs will provide insights and tips on how to improve the odds of successfully obtaining financing during the upcoming “Financing Your Consumer Products Company” seminar.
The Doctor’s Best brand of supplements has been sold to a major Chinese ingredient manufacturer, which is part of a trend in the industry, one observer said.
Another company has reported success with an acquisition in the dietary supplements ingredients space as Hawkins, Inc. reported strong earnings growth attributed in part to its purchase of Stauber.
A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
In US basketball lingo they call it playing small ball. Frutarom, which supplies flavors, fragrances and dietary supplement ingredients, has grown to one of the world’s largest companies in the category by acquiring many of the smallest firms.
Canadian krill oil supplier Neptune Technologies and Bioressources is moving up the value chain by acquiring formulation service provider Biodroga for about $10.6 million (USD).
Hawkins Inc. has announced completion of its acquisition of Stauber Performance Ingredients in a cash for stock transaction valued at $157 million. It’s the second time Stauber has changed hands in recent years.
Marine Ingredients continues to build out its capabilities along the omega-3 value chain with its recent acquisition of a Florida-based softgel manufacturer.
Protein via nutrition bars and other delivery modes has driven much of the recent M&A activity in the dietary supplement and functional foods space, experts say.
French biotech firm Alderys has bought Eviagenics’ micro-organism based flavonoid production platform for an undisclosed sum. The deal will allow Alderys to commercialise the technology and Eviagenics to focus on its seaweed extracts venture.
Kerry Group has splashed out a cool $735m on three US-based companies to expand its taste and nutrition portfolio: Red Arrow Products, Island Oasis and Biothera Inc's Wellmune business.
